Navigation Links
LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
Date:9/18/2007

BOZEMAN, Mont., Sept. 18 /PRNewswire/ -- LigoCyte Pharmaceuticals, Inc., today announced a strategic partnership with Biogen Idec (Nasdaq: BIIB) to develop therapies targeting CD103 for the treatment of chronic inflammatory diseases including potential respiratory, gastrointestinal, and autoimmune indications. CD103 is the unique alphaE-beta7 integrin that has been implicated in the activation, homing and retention of lymphocytes that mediate inflammatory diseases affecting mucosal regions of the intestine, skin, and lungs.

Under terms of the agreement, LigoCyte will receive milestone payments on the successful development of drug candidates. The collaboration includes an opportunity for co-development, co-promotion, and sharing of profits resulting from commercialized products.

"We are very pleased to be entering into this collaboration with Biogen Idec for the development of our lead anti-inflammatory therapy," said Donald P. Beeman, CEO and chairman of the board for LigoCyte. "This strategic alliance confirms the value of LigoCyte's immunology expertise."

About LigoCyte

LigoCyte Pharmaceuticals, Inc., is a privately held biopharmaceutical company developing vaccines and therapeutic monoclonal antibodies focused on important respiratory and gastrointestinal markets. The company is currently investigating its norovirus vaccine in human clinical studies. For more information on LigoCyte, please visit http://www.ligocyte.com.


'/>"/>
SOURCE LigoCyte Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic Protection Against Influenza Challenge With Virus-Like Particle Immunization
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... SANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,I...evelopingproductsforminimallydisruptivesurgicaltre...nferencecallonMonday,November30,2009,at5:30p.m.ET/...esrelativetoreimbursementfortheCompany,sproductsan...questionandanswersession.Thedial-innumbersare1-877...
(Date:11/25/2009)... NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannou...talogue: ,, PainManagement-GlobalTrends ,...gement---Global-Trends.html ,, Widespreadavail...nics,andtheadventofnewdrugshaveacceleratedthepaceo...andreimbursementstructurecontinuetoshapedemandfors...
(Date:11/25/2009)... DELFT,TheNetherlandsandJOHANNESBURG,November25/PR...andPyxisDiscoveryannouncedtoday,thattheyhavesigned...es,services. , Pyxis,sworldclasscomputational...thiThemba,sservicedivisiontoprovidemedicinaland,sy...Pyxis,internationalclientnetwork.iThembaPharmaceu...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Moderate Drinking Guards the Heart 61733 1Moderate Drinking Guards the Heart 61733 2Moderate Drinking Guards the Heart 61733 3Highlighting racial disparities increases coverage and effectiveness of health news 61731 1Highlighting racial disparities increases coverage and effectiveness of health news 61731 2Patients weight not linked to success of fibroid surgery 61729 1Patients weight not linked to success of fibroid surgery 61729 2
...ation for Cancer Research,(AACR) Annual Meeting -,...iotech Inc., a,privately held biopharmaceutical co...ucts focused on cancer, today announced results,of... studies,conducted to evaluate the potential for c...eutic, Proxinium(TM), with first-line,standard of ...
...e/ -- Micell,Technologies announced today that the...ercritical fluid (SCF) surface modification,techno...ty for,Biomaterials 2007 Annual Meeting, April 19-...ribe use of Micell and PNNL,s, 2006 R&D,100 Aw...ng stents,containing crystalline drugs, such as si...
Other Medicine Technology:Viventia biotech reports synergystic effect of its Proxinium,antibody in combinaton with chemotherapy and radiation 2Viventia biotech reports synergystic effect of its Proxinium,antibody in combinaton with chemotherapy and radiation 3Micell Technologies Presents Data on Novel Drug-Eluting Stents 2Micell Technologies Presents Data on Novel Drug-Eluting Stents 3
(Date:11/26/2009)...cations announces a highly effective and unconvent...ing to make an economic recovery. , ...is the type of challenge that could send ailing ho.... David Benton, business growth expert and author ...h; The Rfactor Intensive . “Fear is one o...
(Date:11/25/2009).../--TheBartleHallConventionCenterwilltemporarilybec...ansasCityhoststhelatestinaseriesofmassivefreeclini...sthepotentialtobethebiggestoneyet,becauseitwillext...nsteadofoveraweekend,"SheriWood,executivedirectoro...ionalAssociationofFreeClinics(NAFC). ,, Atprevi...
(Date:11/25/2009)...nelleMedicalInc.,aleadingmanufacturerofbreastMRIco...fnewleadingedgeclinicalapplicationsonitsAegis(TM)m...calSocietyofNorthAmerica(RSNA)annualmeetinginChica...onsleveragetheuniquehighqualityimagesgeneratedbySe...ipleimagingmodalitiesformulti-parametricassessment...
(Date:11/25/2009)...ewswire/--TheBlackAIDSInstituterecentlyheldBoardof...2010. ,, ThenewBoardMembersareahighlydiversegro...ce,governmenthealthprograms,editorial,andbusinesse...ersonalbackgroundsincludingbothheterosexualandgayB...resentingmultipleagegroups. ,, (Photo: http://w...
(Date:11/25/2009)...er who were treated with cisplatin-based chemother...ogical side effects and Raynaud-like phenomena, th...ording to a new study published online November 25.... , Marianne Brydy, M.D., of the Department of O... Norway, and colleagues conducted a cross-sectiona...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...of the DNC bolsters firm,s national government aff...oward Dean -- a nationally recognized political fi... -- has agreed to serve as an independent consulta...he areas of healthcare and alternative energy reso...
...lects company,s complete portfolio of Rx and speci...arch 3 Ortho-McNeil-Janssen Pharmaceuticals, Inc.... is now Ortho Dermatologics. , , The new name ...specialty aesthetic products for medical dermatolo...
...J., March 3 David B. Snow Jr., chairman and chief...NYSE: MHS ), is scheduled to address the Barclay... Wednesday, March 11, 2009. , , The presentation ... , The presentation may be heard live via a simulc...
...orts Significant Growth, Industry Leadership in In... GetWellNetwork, Inc. , the leading provider of ...nounced that it received $10 million in a Series C...luding Valhalla Partners, Grosvenor Funds, Point J...
...lif., March 3 Thoratec Corporation,(Nasdaq: THO...culatory support,therapies to save, support and re...articipating in the Raymond James 30th Annual Inst...the company, beginning at 8:05 a.m., Eastern Dayli...
...ch 3 Each day we have countless conversations wit...iscover that much of what we say to ourselves is c...m to expect perfection, and if we don,t get it, we...ok, "Conversations with Self: Discovering the Powe...
Other Medicine News:Health News:Howard Dean to Join McKenna Long and Aldridge LLP 2Health News:Howard Dean to Join McKenna Long and Aldridge LLP 3Health News:Professional Skin Care Company OrthoNeutrogena Becomes Ortho Dermatologics 2Health News:Medco CEO to Present at the Barclays Capital Global Healthcare Conference 2Health News:GetWellNetwork Closes $10 Million Financing, Eight Hospitals Choose PatientLife System(R) for Unparalleled Patient Care 2Health News:GetWellNetwork Closes $10 Million Financing, Eight Hospitals Choose PatientLife System(R) for Unparalleled Patient Care 3Health News:'Conversations with Self: Discovering the Power of Your Inner Voice': Discover How to Find and Listen to an Inner Voice That Is Encouraging and Helpful 2
Langerman Phaco Chopper
Minardi Phaco Chopper
Alio-Rosen Phaco PreChopper
Ti/HA Peg & Sleeve System
Medicine Products: